Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) — Cash Flow-to-Debt Ratio
Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥9.12 Million could theoretically repay 0% of its total liabilities (CN¥571.21 Million) in one year. See how financially flexible is Shenzhen Bioeasy Biotechnology Co. Ltd. to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shenzhen Bioeasy Biotechnology Co. Ltd. Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Shenzhen Bioeasy Biotechnology Co. Ltd. across 10 annual periods. For the full cash flow conversion analysis, see Shenzhen Bioeasy Biotechnology Co. Ltd. cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)
Year-by-year debt coverage analysis for Shenzhen Bioeasy Biotechnology Co. Ltd.. Check Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.11x | CN¥66.87 Million | CN¥616.87 Million | ▲ +85.7% |
| 2024 | 0.06x | CN¥34.26 Million | CN¥586.92 Million | ▲ +179.5% |
| 2023 | -0.07x | CN¥-37.25 Million | CN¥507.61 Million | ▼ -115.3% |
| 2022 | 0.48x | CN¥152.55 Million | CN¥317.75 Million | ▼ -61.3% |
| 2021 | 1.24x | CN¥255.42 Million | CN¥205.94 Million | ▲ +102.0% |
| 2020 | 0.61x | CN¥63.79 Million | CN¥103.90 Million | ▼ -16.6% |
| 2019 | 0.74x | CN¥67.24 Million | CN¥91.35 Million | ▼ -5.7% |
| 2018 | 0.78x | CN¥57.93 Million | CN¥74.22 Million | ▲ +95.8% |
| 2017 | 0.40x | CN¥23.60 Million | CN¥59.19 Million | ▼ -25.5% |
| 2016 | 0.54x | CN¥36.31 Million | CN¥67.83 Million | — |